- Home
- OMH vs AEON Comparison
OMH vs AEON Comparison
Compare OMH & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- AEON
- Stock Information
- Founded
- OMH 2015
- AEON N/A
- Country
- OMH Singapore
- AEON United States
- Employees
- OMH N/A
- AEON N/A
- Industry
- OMH Real Estate
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- AEON Health Care
- Exchange
- OMH Nasdaq
- AEON Nasdaq
- Market Cap
- OMH 4.6M
- AEON 4.2M
- IPO Year
- OMH 2023
- AEON N/A
- Fundamental
- Price
- OMH $2.11
- AEON $0.46
- Analyst Decision
- OMH Strong Buy
- AEON Strong Buy
- Analyst Count
- OMH 1
- AEON 1
- Target Price
- OMH $15.00
- AEON $360.00
- AVG Volume (30 Days)
- OMH 404.8K
- AEON 465.0K
- Earning Date
- OMH 01-01-0001
- AEON 05-13-2025
- Dividend Yield
- OMH N/A
- AEON N/A
- EPS Growth
- OMH N/A
- AEON N/A
- EPS
- OMH N/A
- AEON 72.93
- Revenue
- OMH $5,390,607.00
- AEON N/A
- Revenue This Year
- OMH $102.52
- AEON N/A
- Revenue Next Year
- OMH $37.92
- AEON N/A
- P/E Ratio
- OMH N/A
- AEON $0.01
- Revenue Growth
- OMH 25.77
- AEON N/A
- 52 Week Low
- OMH $0.25
- AEON $0.38
- 52 Week High
- OMH $3.35
- AEON $402.48
- Technical
- Relative Strength Index (RSI)
- OMH 49.97
- AEON 26.87
- Support Level
- OMH $1.70
- AEON $0.38
- Resistance Level
- OMH $3.77
- AEON $0.43
- Average True Range (ATR)
- OMH 0.44
- AEON 0.04
- MACD
- OMH -0.04
- AEON 0.20
- Stochastic Oscillator
- OMH 19.81
- AEON 56.29
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.